All Infectious Disease articles – Page 2
-
NewsMeasles elimination versus eradication: The difference explained
As of March 13, the CDC has confirmed 301 cases of measles as well as the death of a child in Texas. Amira Roess, an epidemiologist and professor of global health, clarifies the benefits of vaccinating children and adolescents against measles.
-
NewsTadpoles try to flee dangerous virus in their pond by growing much faster than normal
A new study shows that larvae of wood frogs respond to the presence of a deadly ranavirus by growing and maturing precociously. In response to ranavirus, tadpoles change their growth, development, and resource allocation, which may help them tolerate the energetic demands of infection or escape risky environments to avoid infection.
-
NewsC. diff uses toxic compound to fuel growth advantage
The pathogen C. diff — the most common cause of health care-associated infectious diarrhea — can use a compound that kills the human gut’s resident microbes to survive and grow, giving it a competitive advantage in the infected gut.
-
NewsSusceptibility to bovine TB in cattle traced to key genes
A new study identifying genetic factors contributing to bovine tuberculosis (bTB) susceptibility has found several key genes and pathways involved in the bovine response to Mycobacterium bovis, the causative agent of the disease in cattle.
-
NewsNewer hepatitis B vaccine shows promise as booster for health care workers
A new study compares the effectiveness of Heplisav-B, a new hepatitis vaccine, vs. standard hepatitis B vaccines as a booster in previously vaccinated individuals.
-
NewsNew study reveals a safer alternative for long-term hepatitis B treatment
Researchers have studied the effects of switching from long-term tenofovir disoproxil fumarate to the antiviral besifovir dipivoxil maleatein (BSV) in patients with chronic hepatitis B. Switching to BSV may improve patient kidney and bone health.
-
NewsStudy evaluates airborne transmission risk of mpox compared to COVID-19 and smallpox
Scientists have found that the inhaled infectious dose of mpox is at least 100 times lower than that of SARS-CoV-2 and smallpox, making efficient respiratory aerosol transmission highly unlikely in its current form - but future viral evolution could alter this dynamic.
-
NewsUKHSA highlights pathogens of greatest risk to public health in bid to boost preparedness
The UK Health Security Agency (UKHSA) has today published its view on the pathogen families that could pose the greatest risk to public health, in a bid to focus and guide preparedness efforts against these threats.
-
NewsInfluenza of avian origin confirmed in a sheep in Yorkshire
The UK’s Chief Veterinary Officer has confirmed a case of influenza of avian origin (H5N1) in a single sheep in Yorkshire following repeat positive milk testing.
-
NewsResearchers test new, more reliable method to detect chagas disease
Researchers have successfully tested a faster, more sensitive and reliable way to diagnose Chagas disease, a debilitating parasitic illness that affects approximately 6 million people worldwide.
-
NewsMcMaster leads Canada’s first-ever guidelines for Post COVID-19 Condition
A team of experts from McMaster University has led the creation of Canada’s first-ever comprehensive guidelines for diagnosing, managing, preventing, and treating post COVID-19 condition (PCC), more commonly known as long COVID.
-
NewsFour advances that could change tuberculosis treatment
World Tuberculosis Day commemorates Robert Koch’s discovery of the source bacterium Mycobacterium tuberculosis. Scientists are still refining TB diagnosis methods and treatment strategies - some of the latest innovations are revealed here.
-
NewsTuberculosis in children and adolescents: EU/EEA observes a rise in 2023
The notification rate of tuberculosis (TB) went up from 2 to 2.5 per 100,000 population. But overall, numbers of notified paediatric cases remain relatively low across the region.
-
NewsTeam finds regional, age-related trends in exposure to drug-resistant pathogen
A study from 10 US states found drug-resistant Campylobacter jejuni infections were highest in the 20-39 age group and that quinolone-resistant C. jejuni infections increased from 22.6% of those tested in 2013 to 33.54% in 2019. It identified regional differences in C. jejuni resistance to quinolones and six other classes of antibiotics.
-
NewsStudy yields new data on Mpox vaccine effectiveness in people with HIV
A new study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, especially people with HIV, should receive the second dose of the vaccine as recommended.
-
NewsImmature platelet fraction offers clinical predictor for enhanced platelet recovery in patients with dengue fever
Immature platelet fraction (IPF) is recognized as a marker for thrombopoiesis, but a new study indicates that IPF% can be utilized as a predictor of platelet increase in patients with dengue infection.
-
NewsResearch uncovers new strategy to reduce tissue damage from flesh-eating bacteria
A new study reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating bacterium responsible for severe infections such as necrotizing fasciitis.
-
NewsCurrent antivirals likely less effective against severe infection caused by bird flu virus in cows’ milk
Scientists found that in a preclinical model, two FDA–approved flu antivirals generally did not successfully treat severe H5N1 infections. Meanwhile, the route of infection, whether through the eye, the nose or the mouth, significantly impacts effectiveness.
-
NewsMetagenomic analysis of tick-borne viruses in Inner Mongolia
A new study maps the landscape of TBVs in Inner Mongolia, but also highlights the potential spillover risk of TBVs. These findings underscore the urgent need for One Health strategies for monitoring emerging TBVs at the tick-human-livestock interface in northern China.
-
NewsUltra-low dose CT aids pneumonia diagnosis in immunocompromised patients
Denoised ultra-low dose CT can effectively diagnose pneumonia in immunocompromised patients using only 2% of the radiation dose of standard CT, according to a study.